Latest Breaking News On - லிங்க் மருந்துகள் - Page 1 : comparemela.com

Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002

/PRNewswire/ Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as Lynk Pharmaceuticals ), an innovative drug development company, announced today.

Sherry weigandLynk pharmaceuticals co ltdPrnewswire lynk pharmaceuticals co ltdLynk pharmaceuticalsLynk pharmaceuticalsChief medical officerLynk pharmaceuticals coலிங்க் மருந்துகள்தலைமை மருத்துவ அதிகாரி

Lynk Pharmaceuticals Announced Clinical Approval in China of Its New Class I Drug LNK01003

Lynk Pharmaceuticals Announced Clinical Approval in China of Its New Class I Drug LNK01003
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Lynk pharmaceuticals co ltdPrnewswire lynk pharmaceuticals co ltdLynk pharmaceuticalsNational medical products administrationலிங்க் மருந்துகள்